Factors influencing plasma coproporphyrin-I concentration as biomarker of OATP1B activity in patients with rheumatoid arthritis
In conclusion, the present results suggest that inflammatory cytokines do not have clinically significant effects on OATP1B activity, whereas the effects of genetic polymorphisms and uremic toxins should be considered.PMID:34319605 | DOI:10.1002/cpt.2375
Source: Clinical Pharmacology and Therapeutics - Category: Drugs & Pharmacology Authors: Hiroyuki Ono Ryota Tanaka Yosuke Suzuki Ayako Oda Takashi Ozaki Ryosuke Tatsuta Keisuke Maeshima Koji Ishii Keiko Ohno Hirotaka Shibata Hiroki Itoh Source Type: research
More News: Arthritis | Drugs & Pharmacology | Genetics | Organic | Rheumatoid Arthritis | Rheumatology | Study